International journal of radiation oncology, biology, physics
High-Dose REirradiation for In-Field Recurrent Lung Cancer in the THOrax (RETHO): Outcomes of a Phase 2 Prospective Clinical Trial.
Eugenio Cammareri, Marloes Duijm, Patrick V Granton, Wilco Schillemans, Steven Petit, Jose Belderbos, Erik van Werkhoven, Robin Cornelissen, Joost L Knegjens, Joost J Nuyttens
Published: 202510.1016/j.ijrobp.2025.12.024
Abstract
PURPOSE: Locoregional failures after (chemo)radiation therapy for primary lung cancer account for 30% of relapses. Reirradiation in this setting is challenging. To evaluate the outcome after thoracic reirradiation with radical doses, a prospective ph…
Preview only. Read the full abstract at the source